Skip to main content

Table 1 Sample characteristics based on health insurance claims data from 2020 after PSM (shown values: mean ± SD in case of metric data respectively n (%) in case of categorial data; costs are shown in €)

From: COVID-19-associated costs and mortality in Germany: an incidence-based analysis from a payer’s perspective

 

CG 1

n = 4007

IG 1

n = 4007

CG 2

n = 536

IG 2

n = 536

CG 3

n = 3471

IG 3

n = 3471

Age (years)

  ≤ 19

 20–39

 40–59

  ≥ 60

42.0 ± 18.8

588 (14.7)

1096 (27.4)

1657 (41.4)

666 (16.6)

41.8 ± 18.6

536 (13.4)

1178 (29.4)

1680 (41.9)

613 (15.3)

42.4 ± 17.0a

56 (10.4)a

159 (29.7)a

244 (45.5)a

77 (14.4)

46.9 ± 14.6a, b

28 (5.2)a, b

114 (21.3)a, b

318 (59.3)a, b

76 (14.2)

42.0 ± 19.1

532 (15.3)

937 (27.0)a

1413 (40.7)

589 (17.0)

41.0 ± 19.0b

508 (14.6)b

1064 (30.7)a, b

1362 (39.2)b

537 (15.5)

Gender (f / m in %)

53.6 / 46.4

52.7 / 47.3

57.3 / 42.7

56.3 / 43.7

53.1 / 46.9

52.1 / 47.9

Total healthcare costs

 Hospital costs

 Costs of outpatient med. care

 Drug costs

 Costs of sick pay

 Other healthcare costs

2978 ± 8558

927 ± 4457

622 ± 922

452 ± 2296

251 ± 1690

726 ± 4296

3003 ± 8647

839 ± 4248

617 ± 808

544 ± 3514

239 ± 1716

764 ± 4144

3688 ± 9733

1281 ± 5784

714 ± 1166a

568 ± 3291a

348 ± 2034

777 ± 2392

3150 ± 6253b

728 ± 2405

792 ± 1008a, b

487 ± 2519a, b

485 ± 2675b

656 ± 1782b

2868 ± 8359

872 ± 4214

608 ± 878

435 ± 2101

236 ± 1630

718 ± 4519

2980 ± 8960b

856 ± 4465

590 ± 769b

553 ± 3644b

201 ± 1511b

781 ± 4398b

Top-15 Diagnoses

 Essential Hypertension (I10)

 Lipidemia (E78)

 Back pain (M54)

 Type 2 diabetes (E11)

 Other non-toxic goiter (E04)

 Chronic ischemic heart disease (I25)

 Obesity (E66)

 Depressive episode (F32)

 Other diseases of the liver (K76)

 Gastroesophageal Reflux (K21)

 Gastritis and duodenitis (K29)

 Acute infect. in upper resp. tract (J06)

 Other COPD (J44)

 Varices of the lower extremities (I83)

 Bronchial asthma (J45)

982 (24.5)

666 (16.6)

1235 (30.8)

342 (8.5)

380 (9.5)

166 (4.1)

493 (12.3)

512 (12.8)

234 (5.8)

362 (9.0)

349 (8.7)

1057 (26.4)

159 (4.0)

250 (6.2)

394 (9.8)

1009 (25.2)

667 (16.6)

1238 (30.9)

322 (8.0)

338 (8.4)

194 (4.8)

510 (12.7)

497 (12.4)

237 (5.9)

357 (8.9)

325 (8.1)

1024 (25.6)

165 (4.1)

249 (6.2)

388 (9.7)

134 (25.0)a

87 (16.2)a

172 (32.1)a

37 (6.9)

57 (10.6)

20 (3.7)

66 (12.3)

75 (14.0)a

35 (6.5)

56 (10.4)

54 (10.1)

172 (32.1)

22 (4.1)

45 (8.4)

62 (11.6)

173 (32.3)a, b

130 (24.3)a, b

206 (38.4)a, b

46 (8.6)

64 (11.9)b

31 (5.8)

83 (15.5)b

102 (19.0)a, b

44 (8.2)b

72 (13.4)b

58 (10.8)

151 (28.2)

27 (5.0)

38 (7.1)

72 (13.4)b

848 (24.4)

579 (16.7)

1063 (30.6)

305 (8.8)

323 (9.3)

146 (4.2)

427 (12.3)

437 (12.6)

199 (5.7)

306 (8.8)

295 (8.5)

885 (25.5)

137 (3.9)

205 (5.9)

332 (9.6)

836 (24.1)b

537 (15.5)b

1032 (29.7)b

276 (8.0)

274 (7.9)b

163 (4.7)

427 (12.3)b

395 (11.4)b

193 (5.6)b

285 (8.2)b

294 (8.5)

873 (25.2)

138 (4.0)

211 (6.1)

316 (9.1)b

  1. Abbreviations: CG 1–3 Control group to IG 1–3, COPD Chronic obstructive pulmonary disease, f female, IG 1 Investigation group in total, IG 2 Investigation group including Post-COVID-19 Syndrome (PCS) patients only, IG 3 Investigation group excluding PCS patients, m male, n sample size, PSM Propensity score matching, SD Standard deviation
  2. aSignificant difference (p < 0.05) between IG and respective CG (Mann–Whitney U test in case of metric data, χ2 independence test in case of categorial data)
  3. bSignificant difference (p < 0.05) between IG 2 and IG 3 (Mann–Whitney U test in case of metric data, χ2 independence test in case of categorial data)